NSTE-ACS for Professionals

Find the latest resources on how to translate the NSTE-ACS Guidelines into practice

NSTE-ACS (non-ST elevation acute coronary syndrome) can be more challenging to diagnose than STEMI, and treatment options are based on symptoms and other risk factors, including readmission, morbidity and mortality risk. Treatment is divided into invasive (coronary intervention) or noninvasive (medical management) strategies according to the latest guidelines.

Featured Video

Guidelines-on-the-Go

Learn about features of AHA's newest app for professionals, Guidelines On-The-Go. Now you can access AHA's guidelines in an easy-to-read format on your tablet, mobile phone, or desktop.

Guideline Transformation & OptimizationThis NSTE-ACS page for professionals is part of the Guidelines Transformation & Optimization Program and is supported by an educational grant from AstraZeneca. The American Heart Association’s Guideline Transformation & Optimization (GTO) Program is a comprehensive, coordinated approach to accelerate guidelines into clinical practice.

AstraZeneca is a proud inaugural sponsor of the American Heart Association’s Guideline Transformation and Optimization Initiative.